Related references
Note: Only part of the references are listed.Reporting Clinical Studies Affected by the COVID-19 Pandemic: Guidelines for Authors
Roy H. Perlis et al.
JAMA NETWORK OPEN (2021)
Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations
George Lau et al.
HEPATOLOGY INTERNATIONAL (2020)
Preserving Clinical Trial Integrity During the Coronavirus Pandemic
Mary M. McDermott et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic
Bruno H. R. de Paula et al.
LANCET ONCOLOGY (2020)
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Stefan D. Anker et al.
EUROPEAN HEART JOURNAL (2020)
A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic
Suzie Cro et al.
BMC MEDICAL RESEARCH METHODOLOGY (2020)
Implications for Design and Analyses of Oncology Clinical Trials During the COVID-19 Pandemic
Chaya S. Moskowitz et al.
JAMA ONCOLOGY (2020)
COVID-19 Ethics and Research
Karen M. Meagher et al.
MAYO CLINIC PROCEEDINGS (2020)
Changes to aspects of ongoing randomised controlled trials with fixed designs
Xanthi Coskinas et al.
TRIALS (2020)
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial
Bruno M. Tomazini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Managing oncology clinical trials during COVID-19 pandemic
Roberto J. Arai et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2020)
Effect of e-Cigarettes Plus Counseling vs Counseling Alone on Smoking Cessation A Randomized Clinical Trial
Mark J. Eisenberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey
David M. Waterhouse et al.
JCO ONCOLOGY PRACTICE (2020)
Pragmatic Strategy Empowering Paramedics to Assess Low-Risk Trauma Patients With the Canadian C-Spine Rule and Selectively Transport Them Without Immobilization: Protocol for a Stepped-Wedge Cluster Randomized Trial
Christian Vaillancourt et al.
JMIR RESEARCH PROTOCOLS (2020)
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Stefan D. Anker et al.
EUROPEAN HEART JOURNAL (2020)
Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS): A Pragmatic Stepped Wedge Cluster Randomized Trial
Deborah M. Siegal et al.
BLOOD (2019)
Rational and design of the T-STORHM Study: A prospective randomized trial comparing fresh whole blood to blood components for acutely bleeding trauma patients
C. Martinaud et al.
TRANSFUSION CLINIQUE ET BIOLOGIQUE (2019)
Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger
Sheila Isanaka et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ethics review of studies during public health emergencies - the experience of the WHO ethics review committee during the Ebola virus disease epidemic
Emilie Alirol et al.
BMC MEDICAL ETHICS (2017)
Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit The Oxygen-ICU Randomized Clinical Trial
Massimo Girardis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement
Jessie McGowan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
The Impact of Protocol Amendments on Clinical Trial Performance and Cost
Kenneth A. Getz et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2016)
Biomedical research: increasing value, reducing waste
Malcolm R. Macleod et al.
LANCET (2014)
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
An-Wen Chan et al.
ANNALS OF INTERNAL MEDICINE (2013)
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
An-Wen Chan et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Zoonoses 3 Prediction and prevention of the next pandemic zoonosis
Stephen S. Morse et al.
LANCET (2012)
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial
Nicholas D. James et al.
LANCET ONCOLOGY (2012)
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
David Moher et al.
INTERNATIONAL JOURNAL OF SURGERY (2012)
Evidence summaries: the evolution of a rapid review approach
Sara Khangura et al.
SYSTEMATIC REVIEWS (2012)
Failure to report protocol violations in clinical trials: a threat to internal validity?
Elizabeth A. Sweetman et al.
TRIALS (2011)
Guidance for Developers of Health Research Reporting Guidelines
David Moher et al.
PLOS MEDICINE (2010)
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials
Kenneth F. Schulz et al.
PLOS MEDICINE (2010)
The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias
Puvan Tharmanathan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2008)
Early stopping of randomized clinical trials for overt efficacy is problematic
Dirk Bassler et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Ethical issues in stopping randomized trials early because of apparent benefit
Paul S. Mueller et al.
ANNALS OF INTERNAL MEDICINE (2007)
Reproducible research: Moving toward research the public can really trust
Christine Laine et al.
ANNALS OF INTERNAL MEDICINE (2007)
Randomized trials stopped early for benefit -: A systematic review
VM Montori et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Multiplicity in randomised trials II: subgroup and interim analyses
KF Schulz et al.
LANCET (2005)
Share Paper
